• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码RNA miR155HG沉默通过靶向微小RNA-155-5p/酪氨酸酶相关蛋白1轴抑制卵巢癌进展。

Long non-coding RNA miR155HG silencing restrains ovarian cancer progression by targeting the microRNA-155-5p/tyrosinase-related protein 1 axis.

作者信息

Wen Aiping, Luo Le, Du Chengchao, Luo Xin

机构信息

Department of Gynecology and Obstetrics, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China.

Department of Gynecology and Obstetrics, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510630, P.R. China.

出版信息

Exp Ther Med. 2021 Nov;22(5):1237. doi: 10.3892/etm.2021.10672. Epub 2021 Aug 31.

DOI:10.3892/etm.2021.10672
PMID:34539833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8438675/
Abstract

Ovarian cancer (OC) is the third commonest gynecological malignancy worldwide. The long non-coding (lnc)RNA microRNA (miR)155HG functions as an oncogene in different human cancers. However, the function and molecular mechanism of miR155HG in OC remain elusive. The present study indicated that the expression levels of miR155HG and tyrosinase-related protein 1 (TYRP1) were significantly increased, whereas that of miR155-5p was decreased in OC tissues and cells, as detected by real-time quantitative polymerase chain reaction. It was demonstrated that knockdown of miR155HG markedly inhibited OC cell viability, migration and invasion while promoting apoptosis, as indicated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, wound healing, Transwell and western blot assays. Mechanistically, it was revealed that miR155HG and TYRP1 were both targeted by miR-155-5p with complementary binding sites in the 3' untranslated region. A dual-luciferase reporter assay was used to confirm the targeting relationship between miR155HG, miR-155-5p and TYRP1. In addition, the interaction between miR155HG and miR-155-5p was further demonstrated by radioimmunoprecipitation and pull-down assays. In addition, feedback approaches determined that miR-155-5p inhibition or TYRP1 overexpression markedly reversed the inhibitory effects of miR155HG knockdown on OC cell viability, migration and invasion as well as weakened the promotive effect of miR155HG knockdown on OC cell apoptosis. Thus, miR155HG silencing inhibited the malignant biological behavior of OC cells by targeting the miR-155-5p/TYRP1 axis. The present study provides novel insights into the underlying mechanism of OC progression.

摘要

卵巢癌(OC)是全球第三常见的妇科恶性肿瘤。长链非编码(lnc)RNA微小RNA(miR)155HG在不同的人类癌症中发挥癌基因的作用。然而,miR155HG在OC中的功能和分子机制仍不清楚。本研究表明,通过实时定量聚合酶链反应检测发现,miR155HG和酪氨酸酶相关蛋白1(TYRP1)在OC组织和细胞中的表达水平显著升高,而miR155-5p的表达水平降低。3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐、伤口愈合、Transwell和蛋白质印迹分析表明,敲低miR155HG可显著抑制OC细胞活力、迁移和侵袭,同时促进细胞凋亡。机制上,研究发现miR155HG和TYRP1在3'非翻译区均有与miR-155-5p互补的结合位点,二者均为miR-155-5p的靶标。采用双荧光素酶报告基因检测法证实了miR155HG、miR-155-5p和TYRP1之间的靶向关系。此外,放射免疫沉淀和下拉分析进一步证实了miR155HG与miR-155-5p之间的相互作用。此外,反馈方法确定,抑制miR-155-5p或过表达TYRP1可显著逆转敲低miR155HG对OC细胞活力、迁移和侵袭的抑制作用,并减弱敲低miR155HG对OC细胞凋亡的促进作用。因此,miR155HG沉默通过靶向miR-155-5p/TYRP1轴抑制OC细胞的恶性生物学行为。本研究为OC进展的潜在机制提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b288/8438675/22b4e0bda8ca/etm-22-05-10672-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b288/8438675/35c57f41e577/etm-22-05-10672-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b288/8438675/7fef79f17f3c/etm-22-05-10672-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b288/8438675/49eea6a56531/etm-22-05-10672-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b288/8438675/1fbd5d2d053c/etm-22-05-10672-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b288/8438675/e2cc83f336f8/etm-22-05-10672-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b288/8438675/22b4e0bda8ca/etm-22-05-10672-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b288/8438675/35c57f41e577/etm-22-05-10672-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b288/8438675/7fef79f17f3c/etm-22-05-10672-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b288/8438675/49eea6a56531/etm-22-05-10672-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b288/8438675/1fbd5d2d053c/etm-22-05-10672-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b288/8438675/e2cc83f336f8/etm-22-05-10672-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b288/8438675/22b4e0bda8ca/etm-22-05-10672-g05.jpg

相似文献

1
Long non-coding RNA miR155HG silencing restrains ovarian cancer progression by targeting the microRNA-155-5p/tyrosinase-related protein 1 axis.长链非编码RNA miR155HG沉默通过靶向微小RNA-155-5p/酪氨酸酶相关蛋白1轴抑制卵巢癌进展。
Exp Ther Med. 2021 Nov;22(5):1237. doi: 10.3892/etm.2021.10672. Epub 2021 Aug 31.
2
Long non-coding RNA MIR155HG knockdown suppresses cell proliferation, migration and invasion in NSCLC by upregulating TP53INP1 directly targeted by miR-155-3p and miR-155-5p.长链非编码 RNA MIR155HG 敲低通过直接上调 miR-155-3p 和 miR-155-5p 靶向的 TP53INP1 抑制 NSCLC 细胞增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2020 May;24(9):4822-4835. doi: 10.26355/eurrev_202005_21171.
3
Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.长链非编码 RNA UCA1 通过调控 miR-654-5p/SIK2 轴促进卵巢癌对紫杉醇耐药。
Eur Rev Med Pharmacol Sci. 2020 Jan;24(2):591-603. doi: 10.26355/eurrev_202001_20035.
4
TGF-β-induced long non-coding RNA MIR155HG promotes the progression and EMT of laryngeal squamous cell carcinoma by regulating the miR-155-5p/SOX10 axis.TGF-β 诱导的长非编码 RNA MIR155HG 通过调控 miR-155-5p/SOX10 轴促进喉鳞状细胞癌的进展和 EMT。
Int J Oncol. 2019 Jun;54(6):2005-2018. doi: 10.3892/ijo.2019.4784. Epub 2019 Apr 12.
5
lncRNA MIR155HG Accelerates the Progression of Sepsis via Upregulating MEF2A by Sponging miR-194-5p.长链非编码 RNA MIR155HG 通过海绵吸附 miR-194-5p 上调 MEF2A 加速脓毒症的进展。
DNA Cell Biol. 2021 Jun;40(6):811-820. doi: 10.1089/dna.2021.0038. Epub 2021 May 24.
6
LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.LINC-PINT 通过靶向 miR-374a-5p 抑制卵巢癌细胞的增殖、迁移和侵袭。
Cell Biochem Funct. 2020 Dec;38(8):1089-1099. doi: 10.1002/cbf.3565. Epub 2020 Jul 7.
7
Circ_0015756 promotes the progression of ovarian cancer by regulating miR-942-5p/CUL4B pathway.Circ_0015756通过调控miR-942-5p/CUL4B通路促进卵巢癌进展。
Cancer Cell Int. 2020 Nov 27;20(1):572. doi: 10.1186/s12935-020-01666-1.
8
Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma.阻断长链非编码 RNA MIR155HG/miR-155-5p/-3p 抑制肾透明细胞癌的增殖、侵袭和迁移。
Pathol Res Pract. 2020 Feb;216(2):152803. doi: 10.1016/j.prp.2019.152803. Epub 2019 Dec 24.
9
lncRNA SNHG3 acts as oncogene in ovarian cancer through miR-139-5p and Notch1.长链非编码RNA SNHG3通过miR-139-5p和Notch1在卵巢癌中发挥癌基因作用。
Oncol Lett. 2021 Feb;21(2):122. doi: 10.3892/ol.2020.12383. Epub 2020 Dec 17.
10
Long non-coding RNA PVT1-mediated miR-543/SERPINI1 axis plays a key role in the regulatory mechanism of ovarian cancer.长链非编码 RNA PVT1 介导的 miR-543/SERPINI1 轴在卵巢癌的调控机制中起关键作用。
Biosci Rep. 2020 Jun 26;40(6). doi: 10.1042/BSR20200800.

引用本文的文献

1
Diagnostic and Prognostic Roles of miR-155 and miR-3173 in Breast and Ovarian Cancer: Implications for Early Detection and Personalized Treatment.miR-155和miR-3173在乳腺癌和卵巢癌中的诊断及预后作用:对早期检测和个性化治疗的意义
Biomedicines. 2025 Jun 30;13(7):1604. doi: 10.3390/biomedicines13071604.
2
Association of HOTAIR, MIR155HG, TERC, miR-155, -196a2, and -146a Genes Polymorphisms with Papillary Thyroid Cancer Susceptibility and Prognosis.HOTAIR、MIR155HG、TERC、miR-155、-196a2和-146a基因多态性与甲状腺乳头状癌易感性及预后的相关性
Cancers (Basel). 2024 Jan 23;16(3):485. doi: 10.3390/cancers16030485.
3

本文引用的文献

1
MicroRNA-155-5p Diminishes in Vitro Ovarian Cancer Cell Viability by Targeting HIF1α Expression.微小RNA-155-5p通过靶向缺氧诱导因子1α表达降低体外卵巢癌细胞活力。
Adv Pharm Bull. 2020 Sep;10(4):630-637. doi: 10.34172/apb.2020.076. Epub 2020 Aug 9.
2
The 2020 WHO Classification of Tumors of Soft Tissue: Selected Changes and New Entities.《2020 年世卫组织软组织肿瘤分类:精选变更和新实体》。
Adv Anat Pathol. 2021 Jan;28(1):44-58. doi: 10.1097/PAP.0000000000000284.
3
LncRNA MIR155HG Promotes Temozolomide Resistance by Activating the Wnt/β-Catenin Pathway Via Binding to PTBP1 in Glioma.
Liposomal delivery of gene therapy for ovarian cancer: a systematic review.
脂质体基因治疗卵巢癌的系统评价。
Reprod Biol Endocrinol. 2023 Aug 23;21(1):75. doi: 10.1186/s12958-023-01125-2.
4
The strict regulation of HIF-1α by non-coding RNAs: new insight towards proliferation, metastasis, and therapeutic resistance strategies.非编码 RNA 对 HIF-1α 的严格调控:增殖、转移和治疗抵抗策略的新见解。
Cancer Metastasis Rev. 2024 Mar;43(1):5-27. doi: 10.1007/s10555-023-10129-8. Epub 2023 Aug 8.
5
Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis.基于基因表达谱荟萃分析鉴定上皮性卵巢癌中失调的长链非编码 RNA。
Int J Mol Sci. 2023 Jun 28;24(13):10798. doi: 10.3390/ijms241310798.
6
MicroRNA-155-5p, Reduced by Curcumin-Re-Expressed Hypermethylated , Is a Molecular Biomarker for Cancer Risk in -methylation Carriers.姜黄素再表达去甲基化降低的 microRNA-155-5p 是 - 甲基化携带者癌症风险的分子生物标志物。
Int J Mol Sci. 2023 May 19;24(10):9021. doi: 10.3390/ijms24109021.
长链非编码 RNA MIR155HG 通过与 PTBP1 结合激活 Wnt/β-连环蛋白通路促进脑胶质瘤替莫唑胺耐药
Cell Mol Neurobiol. 2021 Aug;41(6):1271-1284. doi: 10.1007/s10571-020-00898-z. Epub 2020 Jun 11.
4
Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis.环状 RNA 0008532 通过调控 miR-155-5p/miR-330-5p/MTGR1 轴促进膀胱癌进展。
J Exp Clin Cancer Res. 2020 May 27;39(1):94. doi: 10.1186/s13046-020-01592-0.
5
Long non-coding RNA MIR155HG knockdown suppresses cell proliferation, migration and invasion in NSCLC by upregulating TP53INP1 directly targeted by miR-155-3p and miR-155-5p.长链非编码 RNA MIR155HG 敲低通过直接上调 miR-155-3p 和 miR-155-5p 靶向的 TP53INP1 抑制 NSCLC 细胞增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2020 May;24(9):4822-4835. doi: 10.26355/eurrev_202005_21171.
6
Ovarian cancer screening: Current status and future directions.卵巢癌筛查:现状与未来方向。
Best Pract Res Clin Obstet Gynaecol. 2020 May;65:32-45. doi: 10.1016/j.bpobgyn.2020.02.010. Epub 2020 Mar 3.
7
Ovarian Cancer Targeted Theranostics.卵巢癌靶向诊疗
Front Oncol. 2020 Jan 21;9:1537. doi: 10.3389/fonc.2019.01537. eCollection 2019.
8
MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.miR-155-5p 通过靶向 IGF2 抑制 PI3K 信号通路发挥抑癌作用,进而抑制肾母细胞瘤的发生发展。
Biomed Pharmacother. 2020 May;125:109880. doi: 10.1016/j.biopha.2020.109880. Epub 2020 Jan 28.
9
Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma.阻断长链非编码 RNA MIR155HG/miR-155-5p/-3p 抑制肾透明细胞癌的增殖、侵袭和迁移。
Pathol Res Pract. 2020 Feb;216(2):152803. doi: 10.1016/j.prp.2019.152803. Epub 2019 Dec 24.
10
LncRNA PCAT6 promotes occurrence and development of ovarian cancer by inhibiting PTEN.长链非编码 RNA PCAT6 通过抑制 PTEN 促进卵巢癌的发生和发展。
Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8230-8238. doi: 10.26355/eurrev_201910_19132.